z-logo
open-access-imgOpen Access
Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis
Author(s) -
Fernándo Alfonso,
Marı́a José Pérez-Vizcayno,
Bruno García del Blanco,
Arturo GarcíaTouchard,
José-Ramón López-Mínguez,
Mónica Masotti,
Javier Zueco,
Rafael Melgares,
Vicente Mainar,
Raúl Moreno,
Antonio Domínguez,
Juan Sanchís,
Armando Bethencourt,
José Moreu,
Ángel Cequier,
Vicens Martı́,
Imanol Otaegui,
Teresa Bastante,
Nieves Gonzalo,
Pilar JiménezQuevedo,
Alberto Cárdenas,
Cristina Fernández
Publication year - 2016
Publication title -
circulation cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.621
H-Index - 95
eISSN - 1941-7632
pISSN - 1941-7640
DOI - 10.1161/circinterventions.115.003479
Subject(s) - medicine , restenosis , stent , drug eluting stent , everolimus , bare metal stent , bare metal , lumen (anatomy) , balloon , target lesion , stenosis , paclitaxel , radiology , cardiology , surgery , percutaneous coronary intervention , myocardial infarction , chemotherapy
Treatment of patients with drug-eluting stent (DES) in-stent restenosis (ISR) is more challenging than that of patients with bare-metal stent ISR. However, the results of everolimus-eluting stents (EES) in these distinct scenarios remain unsettled.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom